Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Leukostasis D018921 1 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Pulmonary Atelectasis D001261 1 associated lipids
Neurologic Manifestations D009461 1 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Dictyocaulus Infections D004022 1 associated lipids
Brain Hemorrhage, Traumatic D020201 1 associated lipids
Migraine without Aura D020326 1 associated lipids
Mouth, Edentulous D009066 1 associated lipids
Anthrax D000881 1 associated lipids
Egg Hypersensitivity D021181 1 associated lipids
Multiple Trauma D009104 2 associated lipids
Amnesia, Anterograde D020324 2 associated lipids
Soft Tissue Injuries D017695 2 associated lipids
Dementia, Multi-Infarct D015161 2 associated lipids
Capillary Leak Syndrome D019559 2 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Hemorrhagic Fever, American D006478 2 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Ileitis D007079 2 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Arnoux B et al. Effect of PAF-acether in non-human primates. 1988 Prog. Clin. Biol. Res. pmid:2837781
Hecker G et al. Potent inhibition of PAF-stimulated human platelets and polymorphonuclear leukocytes by the PGE1 analog OP-1206. 1987 Prog. Clin. Biol. Res. pmid:2444988
Sybertz EJ et al. AGEPC, a vasodilator phospholipid with profound circulatory actions. 1986 Prog. Clin. Biol. Res. pmid:3538024
Karpatkin S et al. Platelet aggregating material (PAM) of two virally-transformed tumors: SV3T3 mouse fibroblast and PW20 rat renal sarcoma. Role of cell surface sialylation. 1982 Prog. Clin. Biol. Res. pmid:7111309
Stjernschantz J and Bito LZ The ocular effects of eicosanoids and other autacoids: historic background and the need for a broader perspective. 1989 Prog. Clin. Biol. Res. pmid:2571999
Valone FH et al. Mechanisms for biphasic or persistent immunologic reactions induced by platelet-activating factor. 1989 Prog. Clin. Biol. Res. pmid:2685826
Piper PJ and Yaacob HB Interactions of platelet activating factor, thromboxane A2 and leukotrienes in guinea-pig heart. 1989 Prog. Clin. Biol. Res. pmid:2508116
Gasser H et al. Effect of platelet-activating factor (PAF) administration in chronically instrumented sheep--analysis of PAF in plasma. 1989 Prog. Clin. Biol. Res. pmid:2780708
Bonavida B et al. The involvement of platelet-activating factor (PAF)-induced monocyte activation and tumor necrosis factor (TNF) production in shock. 1989 Prog. Clin. Biol. Res. pmid:2780710
Heuer H Effect of a new and specific PAF-antagonist, WEB 2086, on PAF and endotoxin/tumor necrosis factor induced changes in mortality and intestinal transit velocity. 1989 Prog. Clin. Biol. Res. pmid:2780739
Camussi G et al. Anti-inflammatory peptides inhibit synthesis of platelet-activating factor. 1990 Prog. Clin. Biol. Res. pmid:2204939
Bahr T et al. Influence of inhibitors of the eicosanoid metabolism, and of eicosanoids- and PAF-acether antagonists on mortality and some biochemical parameters of three shock models. 1989 Prog. Clin. Biol. Res. pmid:2798447
Bradley LM et al. The role of lipid mediators in hypoxic pulmonary vasoconstriction in newborns. 1989 Prog. Clin. Biol. Res. pmid:2798449
Mest HJ et al. The relevance of eicosanoids including PAF for the biochemical regulation of cardiac rhythm. 1989 Prog. Clin. Biol. Res. pmid:2798457
Baker RC Ethanol modulation of the effects of platelet-activating factor on human platelets and a macrophage cell line. 1990 Prog. Clin. Biol. Res. pmid:2300602
Pritze S et al. Effect of platelet-activating factor (PAF) on porcine pulmonary vessels in vitro. 1989 Prog. Clin. Biol. Res. pmid:2798458
Dembinska-Kiec A et al. Release of cysteinyl leukotrienes is of minor importance in platelet-activating factor-induced reduction of perfusion rate in the rat gastric vascular bed. 1989 Prog. Clin. Biol. Res. pmid:2798459
Harper MJ et al. Platelet-activating factor (PAF) and blastocyst-endometrial interactions. 1989 Prog. Clin. Biol. Res. pmid:2542988
Etienne A et al. Possible involvement of platelet-activating factor in endotoxin-induced abortion. 1988 Prog. Clin. Biol. Res. pmid:3393560
McNamara PJ et al. The interaction of alpha-1-acid glycoprotein with endogenous autocoids, in particular, platelet activating factor (PAF). 1989 Prog. Clin. Biol. Res. pmid:2674967
Braquet P and Hosford D The potential role of platelet-activating factor (PAF) in shock, sepsis and adult respiratory distress syndrome (ARDS). 1989 Prog. Clin. Biol. Res. pmid:2675060
Mencia-Hurerta JM et al. The role of platelet-activating factor (PAF) in immune and cytotoxic processes. 1989 Prog. Clin. Biol. Res. pmid:2675061
Heuer H and Casals-Stenzel J The pathophysiological role of PAF in anaphylactic lung reaction in the guinea pig and in endotoxin shock evidenced by the specific PAF-antagonist WEB 2086. 1989 Prog. Clin. Biol. Res. pmid:2675077
Lefer AM Platelet activating factor (PAF) and its role in cardiac injury. 1989 Prog. Clin. Biol. Res. pmid:2678133
Levin M et al. Platelet immune complex interaction in the pathogenesis of Kawasaki disease. 1987 Prog. Clin. Biol. Res. pmid:3423040
Benveniste J Paf-acether, an ether phospho-lipid with biological activity. 1988 Prog. Clin. Biol. Res. pmid:3071808
Dulioust A et al. Immunoregulatory functions of paf-acether (platelet-activating factor). 1988 Prog. Clin. Biol. Res. pmid:3071809
Page CP and Robertson DN The role of PAF in altered airway responsiveness. 1988 Prog. Clin. Biol. Res. pmid:3289016
Schirmer WJ et al. Systemic and renal hemodynamic response to platelet activating factor. 1989 Prog. Clin. Biol. Res. pmid:2726980
Miller CL Infection in massively injured patients. 1982 Prog. Clin. Biol. Res. pmid:6757964
Darius H and Lefer AM Pharmacologic antagonism of platelet activating factor and peptide leukotrienes inhibits guinea pig anaphylaxis. 1987 Prog. Clin. Biol. Res. pmid:3118384
Ishii S and Shimizu T Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. 2000 Prog. Lipid Res. pmid:10729607
Whatley RE et al. Lipid metabolism and signal transduction in endothelial cells. 1990 Prog. Lipid Res. pmid:2128404
Itabe H Oxidized phospholipids as a new landmark in atherosclerosis. 1998 Jul-Aug Prog. Lipid Res. pmid:9829125
Frisardi V et al. Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology. 2011 Prog. Lipid Res. pmid:21703303
Hikiji H et al. The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease. 2008 Prog. Lipid Res. pmid:18187046
Frenkel RA et al. The biochemical role of platelet-activating factor in reproduction. 1996 Prog. Lipid Res. pmid:8944225
Snyder F et al. The role of transacylases in the metabolism of arachidonate and platelet activating factor. 1992 Prog. Lipid Res. pmid:1641397
Tokumura A A family of phospholipid autacoids: occurrence, metabolism and bioactions. 1995 Prog. Lipid Res. pmid:7480064
Lagarde M Metabolism of fatty acids by platelets and the functions of various metabolites in mediating platelet function. 1988 Prog. Lipid Res. pmid:3060881
Hanahan DJ and Kumar R Platelet activating factor; chemical and biochemical characteristics. 1987 Prog. Lipid Res. pmid:3313430
Foegh ML et al. Fatty acids and eicosanoids in organ transplantation. 1986 Prog. Lipid Res. pmid:3321095
Touvay C et al. Proof of the involvement of platelet activating factor (paf-acether) in pulmonary complex immune systems using a specific paf-acether receptor antagonist: BN 52021. 1986 Prog. Lipid Res. pmid:2827186
Damiani E and Ullrich SE Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer. 2016 Prog. Lipid Res. pmid:27073146
Grassi S and Pettorossi VE Synaptic plasticity in the medial vestibular nuclei: role of glutamate receptors and retrograde messengers in rat brainstem slices. 2001 Prog. Neurobiol. pmid:11311461
Maclennan KM et al. Platelet-activating factor in the CNS. 1996 Prog. Neurobiol. pmid:9015828
Lagente V et al. Interference of the PAF-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig. 1987 Prostaglandins pmid:2438723
Wallace JL and Whittle BJ Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants. 1986 Prostaglandins pmid:3726156
McCulloch RK and Vandongen R Mechanisms of platelet activating factor-induced aggregation and secretion in human platelets. 1990 Prostaglandins pmid:2106712
Sakuma Y et al. Inhibitory effects of a novel PAF antagonist E6123 on anaphylactic responses in passively and actively sensitized guinea pigs and passively sensitized mice. 1991 Prostaglandins pmid:1801063
Abstracts of the meeting: The role of platelet-activating factors in the immune response. Paris, France, June 25 and 26, 1987. 1987 Prostaglandins pmid:3671731
Billah MM et al. Platelet-activating factor metabolism in human amnion and the responses of this tissue to extracellular platelet-activating factor. 1985 Prostaglandins pmid:3936121
Acker G et al. Role of platelet-activating factor (PAF) in the ovoimplantation in the rat: effect of the specific PAF-acether antagonist, BN 52021. 1988 Prostaglandins pmid:3129758
Toyofuku T et al. Effects of ONO-6240, a platelet-activating factor antagonist, on endotoxin shock in unanesthetized sheep. 1986 Prostaglandins pmid:3754344
Cucala M et al. Central regulation of gastric acid secretion by platelet-activating factor in anesthesized rats. 1989 Prostaglandins pmid:2499013
Bourgain RH et al. The effect of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (paf-acether) on the arterial wall. 1985 Prostaglandins pmid:3931178
Kuzan FB et al. Role of spermatozoal platelet-activating factor in fertilization. 1990 Prostaglandins pmid:2155438
Dembinska-Kiec A et al. The effects of platelet-activating factor on flow rate and eicosanoid release in the isolated perfused rat gastric vascular bed. 1989 Prostaglandins pmid:2717778
Takehara S et al. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors. 1990 Prostaglandins pmid:1965554
Kaminski DL et al. Studies on the etiology of acute acalculous cholecystitis: the effect of lipopolysaccharide on human gallbladder mucosal cells. 1994 Prostaglandins pmid:8041874
Jancar S et al. Comparative effects of platelet activating factor, leukotriene D4 and histamine on guinea pig trachea, bronchus and lung parenchyma. 1987 Prostaglandins pmid:3588970
Malo PE et al. Enhancement of leukotriene D4-induced contraction of guinea-pig isolated trachea by platelet activating factor. 1987 Prostaglandins pmid:3588971
Madden MC et al. Polarized release of lipid mediators derived from phospholipase A2 activity in a human bronchial cell line. 1994 Prostaglandins pmid:7809385
Bruijnzeel PL et al. Platelet-activating factor induces leukotriene C4 synthesis by purified human eosinophils. 1987 Prostaglandins pmid:3118415
Kikukawa Y et al. The effect of platelet activating factor on ovulation. 1991 Prostaglandins pmid:1775639
Pons L et al. Role of platelet-activating factor (PAF) and prostaglandins in colonic motor and secretory disturbances induced by Escherichia coli endotoxin in conscious rats. 1994 Prostaglandins pmid:8016383
Lee MJ et al. Endothelial cell 1-acyl-platelet-activating factor synthesis in response to anticardiolipin antibody-positive serum fractions. 1994 Prostaglandins pmid:8016391
Kaminski DL et al. The production of experimental cholecystitis by endotoxin. 1994 Prostaglandins pmid:8016392
Ibbotson GC and Wallace JL Beneficial effects of prostaglandin E2 in endotoxic shock are unrelated to effects on PAF-acether synthesis. 1989 Prostaglandins pmid:2727308
Yamanaka S et al. 11-Dehydro thromboxane B2: a reliable parameter of thromboxane A2 production in dogs. 1993 Prostaglandins pmid:8484010
Myers AK et al. Antagonism of PAF-induced death in mice. 1988 Prostaglandins pmid:3131837
Levine L Effects of the protein kinase inhibitors, staurosporine and K-252a, on PGI2 production by rat liver cells (the C-9 cell line). 1990 Prostaglandins pmid:2247616
Whatley RE et al. Relative amounts of 1-O-alkyl- and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells. 1992 Prostaglandins pmid:1546171
Satoh K et al. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease. 1988 Prostaglandins pmid:3399678
Subissi A et al. Effects of anti-asthma drugs on PAF-induced death in mice. 1988 Prostaglandins pmid:2907663
Jager GV et al. Antagonist of platelet-activating factor prevents prostaglandin E2 induced ocular hypertension in rabbits. 1993 Prostaglandins pmid:8424134
Radeau T et al. Enhanced esterification process of 5-hydroxyeicosatetraenoic acid (5-HETE) in PMN from asthmatic patients. 1992 Prostaglandins pmid:1410523
Qu X et al. Endotoxin induces PAF production in the rat ileum: quantitation of tissue PAF by an improved method. 1996 Prostaglandins pmid:8935185
Etienne A et al. Modulation of eosinophil recruitment in the rat by the platelet-activating factor (PAF) antagonist, BN 52021, the somatostatin analog, BIM 23014, and by cyclosporin A. 1989 Prostaglandins pmid:2748916
Morganroth ML et al. Decreased pulmonary vascular responsiveness in rats raised on an essential fatty acid deficient diet. 1987 Prostaglandins pmid:3108962
Terasawa M et al. Pharmacological actions of Y-24180: I. A potent and specific antagonist of platelet-activating factor. 1990 Prostaglandins pmid:2093935
Cirino M et al. A study with BN 52021 demonstrates the involvement of PAF-acether in IgE-dependent anaphylactic bronchoconstriction. 1986 Prostaglandins pmid:3763941
Trochtenberg DS et al. Effects of thromboxane synthase and cyclooxygenase inhibition on PAF-induced changes in lung function and arachidonic acid metabolism. 1992 Prostaglandins pmid:1475377
Kim YD et al. Constriction of canine coronary arteries by platelet activating factor after brief ischemia. 1993 Prostaglandins pmid:8234834
Ashida Y et al. A novel anti-asthmatic quinone derivative, AA-2414 with a potent antagonistic activity against a variety of spasmogenic prostanoids. 1989 Prostaglandins pmid:2748922
Myers SI et al. Platelet activating factor (PAF) stimulates release of PGI2 from inflamed rabbit gallbladder cell cultures. 1995 Prostaglandins pmid:8588069
Guinot P et al. Effect of BN 52063, a specific PAF-acether antagonist, on bronchial provocation test to allergens in asthmatic patients. A preliminary study. 1987 Prostaglandins pmid:3432562
Ernst A et al. The effect of PAF in the cochlea of guinea pigs. 1989 Prostaglandins pmid:2602560
Chan WP and Levy JV Effects of antiplatelet agents on platelet aggregation induced by platelet--activating factor (PAF) in human whole blood. 1991 Prostaglandins pmid:1665568
Sakuma Y et al. Pharmacological effects of oral E6123, a novel PAF antagonist, on biological changes induced by PAF inhalation in guinea pigs. 1991 Prostaglandins pmid:1763202
Camussi G et al. Inhibitory effect of prostacyclin (PGI2) on neutropenia induced by intravenous injection of platelet-activating-factor (PAF) in the rabbit. 1983 Prostaglandins pmid:6346397
Bureau M et al. Desensitization and antagonism of rat polymorphonuclear leukocytes stimulated with PAF acether. 1987 Prostaglandins pmid:3035615
Küster LJ and Frölich JC Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in man. 1986 Prostaglandins pmid:3097760
Moodley I and Stuttle A Evidence for a dual pathway in platelet activating factor-induced aggregation of rat polymorphonuclear leucocytes. 1987 Prostaglandins pmid:3035617
Cordeiro RS et al. Salicylates inhibit PAF-acether-induced rat paw oedema when cyclooxygenase inhibitors are ineffective. 1986 Prostaglandins pmid:3103172
Bonnet J et al. Dependency of the Paf-acether induced bronchospasm on the lipoxygenase pathway in the guinea-pig. 1983 Prostaglandins pmid:6419289
Geissler FT et al. Lipid mediator production by post-implantation rat embryos in vitro. 1989 Prostaglandins pmid:2505333
Fernandes AJ et al. Mechanisms of thrombocytopenia in the acute phase of antigen-induced arthritis in rabbits. 1991 Prostaglandins pmid:1801060
White HL and Faison LD Inhibition of lyso-PAF: acetyl-CoA acetyltransferase by salicylates and other compounds. 1988 Prostaglandins pmid:2903520
Ezra D et al. Cardiac and coronary consequences of intracoronary platelet activating factor infusion in the domestic pig. 1987 Prostaglandins pmid:3685397